Get startedLog in
    Picture of Bavarian Nordic A/S logo

    BAVA — Bavarian Nordic A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Bavarian Nordic Receives Marketing Authorization In Europe For Chikungunya Vaccine For Persons Aged 12 And Older

    Picture of Bavarian Nordic A/S logoBavarian Nordic A/S
    28/02/2025 16:16
    Feb 28 (Reuters) - Bavarian Nordic A/S BAVA.CO:

BAVARIAN NORDIC RECEIVES MARKETING AUTHORIZATION IN EUROPE FOR CHIKUNGUNYA VACCINE FOR PERSONS AGED 12 AND OLDER

BAVARIAN NORDIC - WILL LAUNCH VIMKUNYA IN KEY EUROPEAN MARKETS IN FIRST HALF OF 2025.

Source text: ID:nGNE5fvhTd

Further company coverage: BAVA.CO

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Bavarian Nordic A/S

    See all news